Call for Postdoctoral Research Assignment (GA n.° 101129812 - REGENERAR)

Universidade de Coimbra; Portugal; On-site; EUR 19,000 - 23,000; Full time

Benefits offered by this job

Apoio Horizon Europe

Possibilidade de renovação

Job summary

A Universidade de Coimbra abre uma bolsa de pós-doutoramento no âmbito do projeto REGENERAR, com foco na melhoria da eficácia e segurança da edição epigenética para regeneração cerebral. O projeto envolve cooperação entre universidades e instituições da UE.

O bolseiro contribuirá na avaliação de formulação de entrega, empregando processos de edição de genes em modelos celulares e in vivo, com potencial de renovação conforme o desempenho e as necessidades do projeto.

Qualifications

• Doutoramento na área científica indicada ou equivalente
• Elegibilidade: nacionais da UE/CE, nacionais de terceiros países, apátridas ou refugiados

Responsibilities

• Avaliar formulação de entrega para edição genética em modelos celulares e in vivo.
• Contribuir para o desenvolvimento da pesquisa dentro do projeto REGENERAR.
• Garantir conformidade com os regulamentos de bolsas e divulgação de resultados.

Skills

Cell culture

Immunofluorescence

qRT-PCR

RNA-ISH

Nanotechnology

Education

Doutoramento em Ciências Farmacêuticas

Engenharia Biológica

Engenharia Química

Biologia

Biotecnologia

Engenharia Biológica/Biológica Relacionada

Job description

Organisation/Company Universidade de Coimbra Department Divisão de Projetos e Atividades (Bolsas) Research Field Biological sciences » Other Pharmacological sciences » Other Engineering » Other Other Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Application Deadline 12 Nov 2026 - 23:59 (Europe/Lisbon) Country Portugal Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 23 Oct 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - EIC Reference Number 101129812 Is the Job related to staff position within a Research Infrastructure? No

Offer Description

The University of Coimbra opens a call for the assignment of a postdoctoral research grant, with one position(s), under the project REGENERAR, title Improving the Effectiveness and Safety of Epigenetic Editing in Brain Regeneration (GA n.° 101129812).

The call is governed by this Notice of Opening, the University of Coimbra Research Grant Regulations (RBIUC),subsidiarily by the Research Grant Regulations of the Foundation for Science and Technology (RBIFCT), by the Research Fellow Statute (EBI), by the Norms for Grant Assignment and Management within
R&D Projects, by the Code of Administrative Procedure (CPA), all in their current wording, and by other applicable national and community legislation.

Procedure Reference: IT137-26-458

I - Legal admission requirements
I.I - Grant Recipients:
Holders of a doctoral degree in the scientific area of Pharmaceutical Sciences, Biomedical Engineering,Chemical Engineering, Biology, Biochemistry, Biotechnology, Biological Engineering or related areas, obtained within the three years prior to the start date of the grant, where the research work leading to
the degree was carried out at a host institution different from the one where the work of the current grant will be conducted.

I.II – Ineligible candidates:

• - Candidates who, with the award of the current grant, including possible renewals, exceed a cumulative period of three years in this type of grant, whether consecutive or intermittent.
• - Candidates who obtained their doctoral degree more than three years before the application submission date.
• - Candidates who have conducted the majority of the research work leading to their doctoral degree at the host institution of the current grant.

I.III - Eligible for grant assignment if meeting the requirements:

• a) Portuguese nationals or nationals of other EU Member States
• b) Nationals of third countries
• c) Stateless persons
• d) Beneficiaries of political refugee status

III- Scientific supervision/coordination of the grant: Lino da Silva Ferreira IV - Work Plan / Goals to be achieved:The REGENERAR project aims to develop a non-viral delivery formulation up to TRL 4 for the delivery of a gene-editing formulation. The formulation can be used to induce regeneration in tissues with limited self-repair capacity. The consortium comprises six partners from three EU Member States, including two academic institutions (UC, Portugal, and the University of Munich, Germany), one research institute (Fraunhofer Institute, Germany), one biotechnology SME (ST, Sweden), one large company (Hovione, Portugal), and one project management company (SPI, Portugal). The selected candidate will contribute to the evaluation of a formulation developed within the project, using gene-editing processes in cellular and in vivo models.

V.I - Renewal Possibility: Possibily renewable

VI - Funding and financial conditions of the grant

VI.I - Monthly grant amount (paid by bank transfer at the end of each month):1901,00€

VI.II - Other financial components of the grant: N/A

VI.III - In addition to the above amounts, voluntary social security (SSV) is included when the grant has a duration of six months or more, corresponding to the first level, if the candidate opts for it, as well as mandatory personal accident insurance.

VI.IV - Funding: The grant(s) assigned under this call will be funded by European Union (UE) through the Horizon Europe Program | European Innovation Council and SMEs Executive Agency (EISMEA (EISMEA) | Grant Agreement 101129812.

VI.V - Information and publicity about the funding:In all R&D activities directly or indirectly funded by the grant—specifically, in all communications, publications, and scientific works, as well as theses, produced with the support provided by the grant—acknowledgment must be given to the financial support from the European Union through the Horizon Europe Program, grant number 101129812. The dissemination of research results funded under the RBI must comply with the current open access standards for data, publications, and other research results.

VII - Selection Methods: Evaluation of the academic record (AR) and Interview (I)

VII.I - AR - In the evaluation of the academic record, the candidates' academic performance will be assessed according to the following weights and criteria:

- Criterion 1 - Specific knowledge related o the work plan (The fellow should provide evidence of knowledge in: (i) cell culture (ii) cell characterization (including immunofluorescence, qRT-PCR, RNA-ISH) and (iii) nanotechnology).

VII.II- I –In the evaluation of the interview, candidates' performance will be assessed according to the following weights and criteria:

- Criterion 1 - Motivation and interest

- Criterion 2 – Knowledge and profile appropriate to the functions to be developed

VII.III- The evaluation of the criteria and the final classification will be based on a scale from 0 to 100, with scores rounded to the nearest hundredth, applying the following formulas:

- AR: criterion 1 * 100% = 100%

- I: criterion 1 * 50% + criterion 2 * 50% = 100%

- Final Classification (FC): AR * 40% + I * 60% = 100%

VII.IV - All candidates who meet the admission requirements are subject to the academic record evaluation, carried out according to the criteria and weights defined in VII.I.

VII.V - Candidates who score below 50 in any selection method will be excluded, and subsequent methods, if any, will not apply to them. Candidates who are duly notified but fail to attend the interview (if applicable) or withdraw at any stage will also be excluded.

VII.VI - All candidates who score above 50 in the AR will proceed to the next method, i.e., the interview.

VII.VII - Tie-breaking criteria:In the event of a tie in the rankings, candidates will be ordered in descending order as follows:

• a) Based on the score obtained in the first method applied;
• b) Based on the score of their academic qualifications.

VII.VIII - All provisional and final jury decisions must be justified, recorded in minutes, and published on https://apply.uc.pt/ .

VII.IX -Jury Composition:

IX – Application deadline: 23/10/2026 to 12/11/2026

X - Activity Regime: The grant does not create or constitute a legal-labor relationship. It is carried out under an exclusive dedication regime, and the grantee